Research programme: integrin antagonists - sigma-tau
Alternative Names: ST-1646Latest Information Update: 29 Sep 2010
At a glance
- Originator Ronzoni Institute for Chemical and Biochemical Research; sigma-tau SpA; University of Bari; University of Milan
- Class Cyclic peptides
- Mechanism of Action Angiogenesis inhibitors; Integrin alphaVbeta3 antagonists; Integrin alphaVbeta5 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours